New evidence suggests that the cystic fibrosis transmembrane conductance regulator acts as a specific receptor and clearance mechanism for Pseudomonas aeruginosa.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Pier, G.B., Grout, M. & Zaidi, T.S. Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung. Proc. Natl. Acad. Sci. USA 4, 12088–12093 (1997).
Pier, G.B. et al. Role of mutant CFTR in hypersusceptibility of cystic-fibrosis patients to lung infections. Science 271, 64–67 (1996).
Saiman, L. & Prince, A. Pseudomonas aeruginosa pili bind to asialoGMI which is increased on the surface of cystic fibrosis epithelial cells. J. Clin. Invest. 92, 1875–1880 (1993).
Davies, J.C. et al. CFTR gene transfer reduces the binding of Pseudomonas aeruginosa to cystic fibrosis respiratory epithelium. Am. J. Resp. Cell Mol. Biol. 16, 657–663 (1997).
Smith, J.J., Travis, S.M., Greenberg, E.P. & Welsh, M.J. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85, 229–236 (1996).
Chu, C.-S., Trapnell, B.C., Curristin, S., Cutting, G.R. & Crystal, R.G. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nature Genet. 3, 151–156 (1993).
Tang, H., Kays, M. & Prince, A. Role of Pseudomonas aeruginosa pili in acute pulmonary infection. Infect. Immun. 63, 1278–1285 (1995).
Fleiszig, S.M.J., Zaidi, T.S. & Pier, G.B. Pseudomonas aeruginosa invasion of and multiplication within corneal epithelial cells in vitro. Infect. Immun. 63, 4072–4077 (1995).
Walker, J., Watson, J., Holmes, C., Edelman, A. & Banting, G. Production and characterisation of monoclonal and polyclonal antibodies to different regions of the cystic fibrosis transmembrane conductance regulator (CFTR): detection of immunologically related proteins. J. Cell Sci. 108, 2433–2444 (1995).
McLachlan, G. & Porteous, D.J. The role of mouse models in the development of new therapies for cystic fibrosis. In Transgenic Animals: Generation and Use (ed. Houdebine, L. M.) 435–444 (Harwood Academic Press, Amsterdam, 1997).
Davidson, D.J. et al. Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens. Nature Genet. 9, 351–357 (1995).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Porteous, D., Davidson, D. Cystic fibrosis lung infection cleared up?. Nat Med 3, 1317–1318 (1997). https://doi.org/10.1038/nm1297-1317
Issue Date:
DOI: https://doi.org/10.1038/nm1297-1317
